BRPI1015941A2 - formulações de comprimido de 3-cianoquinolina e uso das mesmas. - Google Patents
formulações de comprimido de 3-cianoquinolina e uso das mesmas.Info
- Publication number
- BRPI1015941A2 BRPI1015941A2 BRPI1015941A BRPI1015941A BRPI1015941A2 BR PI1015941 A2 BRPI1015941 A2 BR PI1015941A2 BR PI1015941 A BRPI1015941 A BR PI1015941A BR PI1015941 A BRPI1015941 A BR PI1015941A BR PI1015941 A2 BRPI1015941 A2 BR PI1015941A2
- Authority
- BR
- Brazil
- Prior art keywords
- cyanoquinoline
- tablet formulations
- formulations
- tablet
- cyanoquinoline tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22253709P | 2009-07-02 | 2009-07-02 | |
PCT/US2010/040555 WO2011002857A2 (en) | 2009-07-02 | 2010-06-30 | 3-cyanoquinoline tablet formulations and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1015941A2 true BRPI1015941A2 (pt) | 2016-04-19 |
Family
ID=42732381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1015941A BRPI1015941A2 (pt) | 2009-07-02 | 2010-06-30 | formulações de comprimido de 3-cianoquinolina e uso das mesmas. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP2448563A2 (es) |
JP (1) | JP2011012063A (es) |
KR (1) | KR20120046216A (es) |
CN (1) | CN102470109A (es) |
AR (1) | AR077546A1 (es) |
AU (1) | AU2010266342A1 (es) |
BR (1) | BRPI1015941A2 (es) |
CA (1) | CA2766067A1 (es) |
IL (1) | IL217298A0 (es) |
MX (1) | MX2012000048A (es) |
RU (1) | RU2011152105A (es) |
SG (1) | SG177309A1 (es) |
TW (1) | TW201113050A (es) |
WO (1) | WO2011002857A2 (es) |
ZA (1) | ZA201200366B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1848414T3 (pl) | 2005-02-03 | 2011-10-31 | Wyeth Llc | Sposób leczenia nowotworu opornego na gefitinib |
EP1942937A1 (en) | 2005-11-04 | 2008-07-16 | Wyeth | Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
ES2609232T3 (es) | 2008-06-17 | 2017-04-19 | Wyeth Llc | Combinaciones antineoplásicas que contienen HKI-272 y vinorelbina |
EP3175853B1 (en) | 2008-08-04 | 2023-11-01 | Wyeth LLC | Antineoplastic combinations of neratinib and capecitabine |
FI3000467T3 (fi) | 2009-04-06 | 2023-03-28 | Wyeth Llc | Rintasyöpähoitokuuri, jossa käytetään neratinibia |
CN107308130B (zh) | 2009-11-09 | 2021-06-15 | 惠氏有限责任公司 | 包衣药物球状体及消除或减少病症如呕吐和腹泻的用途 |
NZ599763A (en) * | 2009-11-09 | 2014-06-27 | Wyeth Llc | Tablet formulations of neratinib maleate |
CN104447541A (zh) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 博舒替尼化合物 |
CN105384686B (zh) * | 2014-09-04 | 2019-07-26 | 连云港润众制药有限公司 | 一种博舒替尼结晶方法 |
WO2017175855A1 (en) * | 2016-04-08 | 2017-10-12 | Shionogi & Co., Ltd. | Stabilized solid dosage form |
JP7086938B2 (ja) | 2017-03-31 | 2022-06-20 | 日精エー・エス・ビー機械株式会社 | 樹脂製容器 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297258B1 (en) | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
AU2003208444B2 (en) * | 2002-02-26 | 2006-10-26 | Astrazeneca Ab | Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
BRPI0413667A (pt) | 2003-08-19 | 2006-10-24 | Wyeth Corp | Processo para a preparação de 4-amino-3-carbonitrilas de quinolina |
US8969379B2 (en) * | 2004-09-17 | 2015-03-03 | Eisai R&D Management Co., Ltd. | Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide |
KR20080028386A (ko) * | 2005-07-01 | 2008-03-31 | 와이어쓰 | 4-[(2,4-디클로로-5-메톡시페닐)아미노]-6-메톡시-7-[3-(4-메틸-1-피페라지닐)프로폭시]-3-퀴놀린카르보니트릴의결정형 형태 및 그의 제조 방법 |
WO2008053295A2 (en) * | 2006-10-30 | 2008-05-08 | Wockhardt Research Centre | Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid |
CN101224185A (zh) * | 2007-12-11 | 2008-07-23 | 山东蓝金生物工程有限公司 | 一种治疗实体肿瘤的伯舒替尼缓释植入剂 |
-
2010
- 2010-06-30 KR KR1020127002851A patent/KR20120046216A/ko not_active Application Discontinuation
- 2010-06-30 CN CN2010800294791A patent/CN102470109A/zh active Pending
- 2010-06-30 SG SG2011094950A patent/SG177309A1/en unknown
- 2010-06-30 CA CA2766067A patent/CA2766067A1/en not_active Abandoned
- 2010-06-30 MX MX2012000048A patent/MX2012000048A/es not_active Application Discontinuation
- 2010-06-30 EP EP10732568A patent/EP2448563A2/en not_active Withdrawn
- 2010-06-30 AU AU2010266342A patent/AU2010266342A1/en not_active Abandoned
- 2010-06-30 BR BRPI1015941A patent/BRPI1015941A2/pt not_active Application Discontinuation
- 2010-06-30 RU RU2011152105/15A patent/RU2011152105A/ru unknown
- 2010-06-30 WO PCT/US2010/040555 patent/WO2011002857A2/en active Application Filing
- 2010-07-01 JP JP2010151063A patent/JP2011012063A/ja not_active Withdrawn
- 2010-07-01 TW TW099121740A patent/TW201113050A/zh unknown
- 2010-07-02 AR ARP100102373A patent/AR077546A1/es not_active Application Discontinuation
-
2011
- 2011-12-29 IL IL217298A patent/IL217298A0/en unknown
-
2012
- 2012-01-17 ZA ZA2012/00366A patent/ZA201200366B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102470109A (zh) | 2012-05-23 |
JP2011012063A (ja) | 2011-01-20 |
SG177309A1 (en) | 2012-02-28 |
EP2448563A2 (en) | 2012-05-09 |
IL217298A0 (en) | 2012-02-29 |
CA2766067A1 (en) | 2011-01-06 |
AU2010266342A1 (en) | 2012-01-19 |
RU2011152105A (ru) | 2013-08-10 |
ZA201200366B (en) | 2012-10-31 |
KR20120046216A (ko) | 2012-05-09 |
TW201113050A (en) | 2011-04-16 |
WO2011002857A3 (en) | 2011-03-10 |
MX2012000048A (es) | 2012-01-27 |
AR077546A1 (es) | 2011-09-07 |
WO2011002857A2 (en) | 2011-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2020003I1 (lt) | Dvisluoksnės tabletės formuluotės | |
BRPI1015941A2 (pt) | formulações de comprimido de 3-cianoquinolina e uso das mesmas. | |
BRPI1008709A2 (pt) | composições e usos das mesmas. | |
BR112012013148A2 (pt) | formulação farmacêutica e uso | |
BR112012005736A2 (pt) | di-hidro benzocicloalquiloximetil oxazolapirimidinonas substituídas, preparação e uso das mesmas | |
BRPI1014160A2 (pt) | Formulações de nanopartículas e aplicações das mesmas | |
BR112012011733A2 (pt) | formulações de comprimido de liberação imediata | |
BRPI0911656A2 (pt) | formulações de nanopartículas e usos das mesmas | |
BR112012003792A2 (pt) | gel tópico, e, uso do gel tópico. | |
SMT201400069B (it) | Formulazione farmaceutica | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
BRPI1016117A8 (pt) | derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
GT201200303A (es) | Formulaciones farmacéuticas | |
BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
BR112012003844A2 (pt) | vacinas de pttv e diagnóstico | |
BRPI1014388A2 (pt) | preparação de sólido. | |
BRPI1014898A2 (pt) | cosmético capilar. | |
BRPI0915527A2 (pt) | pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos | |
BR112012002311A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
BRPI0907700A2 (pt) | Imidazopiridazinas como inibidores par1, produção das mesmas e uso como medicamentos | |
BR112012014495A2 (pt) | cosmético de autonivelamento. | |
BR112012002293A2 (pt) | composto, composição farmacêutica, e, uso do composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |